Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on August 21, 2018. The report discloses the entry into a material definitive agreement regarding executive compensation and the appointment of certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific equity award transaction.
Material Changes
The primary material change reported is the approval of a stock option grant to Michael Arends under the 2012 Stock Incentive Plan. The grant details are as follows:
- Shares Granted: 68,000 shares of Class B Common Stock.
- Exercise Price: $2.69 per share (closing price on the Grant Date).
- Option Type: Incentive stock option to the extent permitted by the Internal Revenue Code, otherwise a nonqualified stock option.
- Vesting Schedule: 25% vests on the first annual anniversary of the Grant Date; the remainder vests quarterly (1/12th) over the following three years, subject to continued employment.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific compensation arrangement described.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2012 Stock Incentive Plan to assess remaining capacity for future grants.
- Confirm the current employment status of Michael Arends to ensure vesting conditions are being met.
- Review the company's most recent 10-Q or 10-K for comprehensive financial performance data, as this 8-K contains no financial results.